“…Higher body mass has been consistently linked with increased inflammation (Visser et al, 1999 andWisse, 2004) as well as lower cognitive functioning (Benito-León et al, 2013, Cournot et al, 2006and Memel et al, 2016, and higher levels of inflammation predicts cognitive decline (Perry et al, 2007, Tegeler et al, 2016, Teunissen et al, 2003and Yaffe et al, 2003, but no previous studies have tested the associations body mass, inflammation, and cognitive decline in a single, integrated model. Once a robust link between a biometric risk factor, such as body mass, and an outcome of clinical interest is established, it essential to test the more proximal potential biological mechanisms that might help explain this association using mediation models that integrate the relevant biological intermediary into the pathways from risk factor to outcome (Miller et al, 2009). Our measure of circulating inflammation, CRP (a measure of systemic inflammation in the periphery), evidenced a significant indirect effect that accounted for the association between body mass and cognition; circulating levels of systemic inflammation are associated neuro-inflammation (Marsland et al, 2015, Perry, 2004and Perry, 2010).…”